Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
AIDS ; 26(12): 1517-22, 2012 Jul 31.
Article in English | MEDLINE | ID: mdl-22555160

ABSTRACT

OBJECTIVE: Recent studies have suggested that the dynamics of HIV-1 evolutionary rate reflect the rate of disease progression. We wished to determine whether viral diversity early in infection is predictive of the subsequent disease course. DESIGN: HIV-1 envelope diversity at seroconversion and 1 year thereafter from 89 homosexual participants of the Amsterdam Cohort Studies on HIV infection and AIDS was correlated with clinical endpoints and markers of disease progression. METHODS: Heteroduplex mobility assay (HMA) and sequencing followed by calculation of pairwise genetic distances were applied to determine HIV-1 envelope diversity. The HMA pattern (presence or absence of heteroduplexes) and sequence diversity were each tested for correlation with the clinical course of infection. RESULTS: HMA pattern at 1-year postseroconversion was significantly associated with progression to AIDS and AIDS-related death, with presence of heteroduplexes associated with accelerated disease progression. Moreover, not only this dichotomous measure of viral diversity (absence or presence of heteroduplexes), but also genetic diversity itself was associated with disease course. HMA pattern was an independent predictor of accelerated disease progression, also when CCR5 genotype, human leukocyte antigen (HLA)-type, viral load, CD4 T-cell counts, and coreceptor use at viral load set point were included in the analysis. CONCLUSION: Viral diversity early in HIV-1 infection is predictive of the subsequent disease progression. It remains to be established whether viral diversity itself plays a causal role in the increased damage to the immune system or whether it is a reflection of immune pressure or other selective forces.


Subject(s)
HIV Infections/virology , HIV Seropositivity/virology , HIV-1/immunology , Viral Envelope Proteins/genetics , Acquired Immunodeficiency Syndrome/mortality , Acquired Immunodeficiency Syndrome/virology , Biomarkers/blood , CD4-Positive T-Lymphocytes , Disease Progression , HIV Infections/genetics , HIV Seropositivity/genetics , HIV-1/genetics , HLA Antigens/immunology , Heteroduplex Analysis , Homosexuality, Male , Humans , Male , Prospective Studies , RNA, Viral/immunology , Receptors, CCR5/immunology , Time Factors , Viral Load
2.
Virology ; 422(1): 70-80, 2012 Jan 05.
Article in English | MEDLINE | ID: mdl-22047989

ABSTRACT

To trace the evolutionary patterns underlying evolution of coreceptor use within a host, we studied an HIV-1 transmission pair involving a donor who exclusively harbored CCR5-using (R5) variants throughout his entire disease course and a recipient who developed CXCR4-using variants. Over time, R5 variants in the donor optimized coreceptor use, which was associated with an increased number of potential N-linked glycosylation sites (PNGS) and elevated V3 charge in the viral envelope. Interestingly, R5 variants that were transmitted to the recipient preserved the viral characteristics of this late stage genotype and phenotype. Following a selective sweep, CXCR4-using variants subsequently emerged in the recipient coinciding with a further increase in the number of PNGS and V3 charge in the envelope of R5 viruses. Although described in a single transmission pair, the transmission and subsequent persistence of R5 variants with late stage characteristics demonstrate the potential for coreceptor use adaptation at the population level.


Subject(s)
HIV Envelope Protein gp120/chemistry , HIV Envelope Protein gp120/genetics , HIV Infections/virology , HIV-1/genetics , Receptors, CCR5/metabolism , Receptors, CXCR4/metabolism , Viral Envelope Proteins/genetics , Amino Acid Sequence , Evolution, Molecular , Glycosylation , HIV Envelope Protein gp120/metabolism , HIV Infections/genetics , HIV Infections/transmission , HIV-1/physiology , Humans , Peptide Fragments/chemistry , Peptide Fragments/metabolism , Phylogeny , Receptors, CCR5/genetics , Receptors, CXCR4/genetics , Sequence Alignment
3.
J Infect Dis ; 203(11): 1621-8, 2011 Jun 01.
Article in English | MEDLINE | ID: mdl-21592992

ABSTRACT

BACKGROUND: Human immunodeficiency virus type 1 (HIV-1) superinfection is infection of an HIV-1 seropositive individual with another HIV-1 strain. The rate at which HIV-1 superinfection occurs might be influenced by sexual behavior. Superinfection might be detected more often by analyzing longitudinal samples collected from time periods of unsafe sexual behavior. METHODS: Envelope C2-C4 and gag sequences were generated from HIV-1 RNA from longitudinal serum samples that were obtained around self-reported sexual risk periods from 15 homosexual therapy-naïve men who participated in the Amsterdam Cohort Studies on HIV Infection and AIDS. Maximum likelihood phylogenetic analysis was used to determine whether HIV-1 superinfection had occurred. RESULTS: We studied a total of 124 serum samples from 15 patients with a median of 8 samples and of 5.8 person-years of follow-up per patient. Phylogenetic analysis on 907 C2-C4 env and 672 gag sequences revealed no case of HIV-1 superinfection, resulting in a superinfection incidence rate of 0 per 100 person-years [95%CI: 0 - -4.2]. CONCLUSIONS: We conclude that HIV-1 superinfection incidence is low in this subgroup of homosexual men who reported unsafe sexual behavior. Additional studies are required to estimate the impact of also other factors, which may determine the risk to acquire HIV-1 superinfection.


Subject(s)
HIV Infections/epidemiology , HIV-1/isolation & purification , Homosexuality, Male/statistics & numerical data , Superinfection/epidemiology , Superinfection/virology , Unsafe Sex/statistics & numerical data , Genes, env , Genes, gag , HIV Infections/blood , HIV Infections/virology , HIV-1/genetics , Humans , Male , Netherlands/epidemiology , Phylogeny , Prospective Studies , RNA, Viral/blood , RNA, Viral/chemistry , Risk-Taking , Superinfection/blood
4.
AIDS ; 25(8): 1035-9, 2011 May 15.
Article in English | MEDLINE | ID: mdl-21505318

ABSTRACT

OBJECTIVE: To investigate whether time-measured phylogenetic analysis of longitudinal viral sequences can establish the direction and timing of HIV-1 transmission in an epidemiologically linked transmission cluster of three homosexual men. DESIGN: An HIV-1-infected homosexual man (patient 1) and his long-term HIV-negative partner (patient 2) engaged in a triangular relationship with an additional partner (patient 3). On the basis of phylogenetic analysis of gag sequences, patient 3 was previously identified as the source for superinfection of patient 1 but the source of HIV-1 infection of patient 2, who seroconverted during the triangular relationship, remained unclear. Here, we set out to analyze newly obtained gag, pol and env sequences from all three patients to fully elucidate the transmission history in this epidemiologically linked cluster. METHODS: Bayesian Markov Chain Monte Carlo (MCMC) phylogenetic analyses incorporating a relaxed clock model and a flexible Bayesian skyride tree prior were applied to the longitudinally obtained gag, pol and env sequences from all three patients. RESULTS: Our time-measured evolutionary reconstructions convincingly supported transmission of HIV-1 from the new partner patient 3 to both patients 1 and 2. In addition, estimates of viral divergence times assisted in narrowing down the transmission intervals delineated by seroconversion estimates. CONCLUSION: Our analysis implies that Bayesian MCMC phylogenetic reconstruction incorporating temporal information can indeed reveal the direction of multiple HIV-1 transmission events in an epidemiologically linked cluster and provide more detail on the timing of transmission.


Subject(s)
Genes, env/genetics , Genes, gag/genetics , Genes, pol/genetics , HIV Infections/genetics , HIV-1/genetics , Phylogeny , RNA, Viral/genetics , Bayes Theorem , HIV Infections/transmission , Homosexuality , Humans , Male , Molecular Sequence Data , Sexual Behavior , Sexual Partners/classification
5.
Virology ; 405(2): 492-504, 2010 Sep 30.
Article in English | MEDLINE | ID: mdl-20638697

ABSTRACT

The HIV-1 quasispecies in peripheral blood mononuclear cells (PBMC) is considered to be a mix of actively replicating, latent, and archived viruses and may be genetically distinct from HIV-1 variants in plasma that are considered to be recently produced. Here we analyzed the genetic relationship between gp160 env sequences from replication competent clonal HIV-1 variants that were isolated from PBMC and from contemporaneous HIV-1 RNA in serum and HIV-1 proviral DNA in PBMC of four longitudinally studied therapy naïve HIV-1 infected individuals. Replication competent clonal HIV-1 variants, HIV-1 RNA from serum, and HIV-1 proviral DNA from PBMC formed a single virus population at most time points analyzed. However, an under-representation in serum of HIV-1 sequences with predicted CXCR4 usage was sometimes observed implying that the analysis of viral sequences from different sources may provide a more complete assessment of the viral quasispecies in peripheral blood in vivo.


Subject(s)
DNA, Viral , Genetic Variation , HIV-1/genetics , Leukocytes, Mononuclear/virology , Proviruses , RNA, Viral , CD4 Lymphocyte Count , Cloning, Molecular , DNA, Viral/analysis , DNA, Viral/genetics , DNA, Viral/isolation & purification , HIV Envelope Protein gp160/chemistry , HIV Envelope Protein gp160/genetics , HIV Infections/virology , HIV-1/classification , HIV-1/isolation & purification , HIV-1/physiology , Humans , Proviruses/genetics , Proviruses/isolation & purification , RNA, Viral/blood , RNA, Viral/genetics , Receptors, CCR5/metabolism , Receptors, CXCR4/metabolism , Viral Load , Virus Replication
6.
Clin Infect Dis ; 50(9): 1309-15, 2010 May 01.
Article in English | MEDLINE | ID: mdl-20367230

ABSTRACT

BACKGROUND: Incidence rates of human immunodeficiency virus type 1 (HIV-1) superinfection differ among cohorts and, as yet, only 2 cohorts of homosexual men have been screened. Here, we investigated the incidence of HIV-1 superinfection during the first year after infection among homosexual participants in the Amsterdam Cohort Studies on HIV infection and AIDS who seroconverted between 1985 and 1997. METHODS: We analyzed env C2-C4 diversity in the serum of therapy-naive participants, using a heteroduplex mobility assay; heteroduplexes were considered to be indicators of potential dual infections, in which case env C2-C4 polymerase chain reaction (PCR) products were cloned and sequenced. Sequences were subjected to phylogenetic analysis. Data on the sexual behavior of participants were collected from 1 year before seroconversion until the end of the investigated period. RESULTS: For 89 seroconverters with a detectable viral load (>1000 copies/mL), env PCR products were generated from serum samples obtained at seroconversion and 1 year later. Heteroduplexes were observed in 68 of the 89 patients; among these 68 patients, a median of 9 molecular clones per time point was sequenced. Phylogenetic analysis did not reveal evidence for superinfection; 1 patient was HIV-1 coinfected. Shortly after diagnosis of HIV infection, the number of sex partners decreased, the frequency of anal intercourse declined, and condom use increased. CONCLUSIONS: The incidence of HIV-1 superinfection soon after seroconversion in this cohort is low. Risk reduction shortly after HIV-1 diagnosis early during the HIV-1 epidemic in the Netherlands may have contributed to the absence of HIV-1 superinfection observed in this study.


Subject(s)
HIV Infections/epidemiology , HIV Infections/virology , HIV-1/isolation & purification , Homosexuality, Male , Risk-Taking , Superinfection/epidemiology , Superinfection/virology , Cluster Analysis , HIV-1/classification , Heteroduplex Analysis , Humans , Incidence , Male , Netherlands/epidemiology , Phylogeny , Sequence Analysis, DNA , env Gene Products, Human Immunodeficiency Virus/genetics
7.
J Virol Methods ; 165(2): 311-7, 2010 May.
Article in English | MEDLINE | ID: mdl-20178816

ABSTRACT

The aim of this study was to compare sensitivity thresholds of two pre-screening methods - the heteroduplex mobility assay (HMA) and the presence of ambiguity codes in population-based sequences - applied for detection of HIV-1 superinfection. HIV-1 env C2-C4 PCR products generated from 48 serum samples isolated from 24 HIV-1 positive and therapy-naïve homosexual men at seroconversion and at approximately 1 year thereafter were subjected to HMA and population sequencing. Clonal sequence analysis was used to determine the sensitivity of each method to detect sequence variability. Results from HMA were compared to pairwise genetic distance of clonal sequences; heteroduplexes resulted from as little as 1.4% pairwise distance between two sequences and were detected even when only 1.5% of the pairwise distance comparisons exceeded this distance threshold. By contrast, the ambiguity code approach using population-based sequencing detected only 20.1% of existing sequence variation and was less sensitive to minority populations

Subject(s)
Electrophoretic Mobility Shift Assay/methods , HIV Infections/diagnosis , HIV-1/isolation & purification , Heteroduplex Analysis/methods , Superinfection/diagnosis , HIV Infections/virology , HIV-1/genetics , Homosexuality, Male , Humans , Male , Polymerase Chain Reaction , Sensitivity and Specificity , Superinfection/virology , env Gene Products, Human Immunodeficiency Virus/genetics
8.
Clin Infect Dis ; 47(11): e86-9, 2008 Dec 01.
Article in English | MEDLINE | ID: mdl-18947331

ABSTRACT

A human immunodeficiency virus type 1 (HIV-1)-infected elite controller (defined as an untreated HIV-1-infected person with a plasma HIV-1 RNA level <50 copies/mL for at least 12 months) who experienced a viremic episode after superinfection regained natural viremic control, although the viral loads in the patient's 2 partners, infected with the same viral strain, were continuously approximately 30-fold higher. Thus, host mechanisms seem to be able to repeatedly control HIV-1 replication, halting disease progression.


Subject(s)
HIV Infections/immunology , HIV Long-Term Survivors , HIV-1/immunology , Superinfection/immunology , CD4 Lymphocyte Count , Humans , Male , Middle Aged , RNA, Viral/blood , Viral Load , Viremia
9.
BMC Cancer ; 8: 292, 2008 Oct 08.
Article in English | MEDLINE | ID: mdl-18842121

ABSTRACT

BACKGROUND: In recent years, numerous studies have investigated somatic mutations in mitochondrial DNA in various tumours. The observed high mutation rates might reflect mitochondrial deregulation; consequently, mutation analyses could be clinically relevant. The purpose of this study was to determine if mutations in the mitochondrial D-loop region and/or the level of mitochondrial gene expression could influence the clinical course of human ovarian carcinomas. METHODS: We sequenced a 1320-base-pair DNA fragment of the mitochondrial genome (position 16,000-750) in 54 cancer samples and in 44 corresponding germline control samples. In addition, six transcripts (MT-ATP6, MT-CO1, MT-CYB, MT-ND1, MT-ND6, and MT-RNR1) were quantified in 62 cancer tissues by real-time RT-PCR. RESULTS: Somatic mutations in the D-loop sequence were found in 57% of ovarian cancers. Univariate analysis showed no association between mitochondrial DNA mutation status or mitochondrial gene expression and any of the examined clinicopathologic parameters. A multivariate logistic regression model revealed that the expression of the mitochondrial gene RNR1 might be used as a predictor of tumour sensitivity to chemotherapy. CONCLUSION: In contrast to many previously published papers, our study indicates rather limited clinical relevance of mitochondrial molecular analyses in ovarian carcinomas. These discrepancies in the clinical utility of mitochondrial molecular tests in ovarian cancer require additional large, well-designed validation studies.


Subject(s)
DNA, Mitochondrial/genetics , Gene Expression , Genes, Mitochondrial , Mutation , Ovarian Neoplasms/genetics , Analysis of Variance , Antineoplastic Agents/therapeutic use , DNA-Binding Proteins , Female , Humans , Ovarian Neoplasms/drug therapy , Reverse Transcriptase Polymerase Chain Reaction , Sequence Analysis, DNA , Statistics, Nonparametric
10.
PLoS One ; 3(6): e2422, 2008 Jun 18.
Article in English | MEDLINE | ID: mdl-18560583

ABSTRACT

BACKGROUND: To address evolution of HIV-1 after transmission, we studied sequence dynamics in and outside predicted epitopes of cytotoxic T lymphocytes (CTL) in subtype B HIV-1 variants that were isolated from 5 therapy-naive horizontal HLA-disparate donor-recipient pairs from the Amsterdam Cohort Studies on HIV-1 infection and AIDS. METHODOLOGY/PRINCIPAL FINDINGS: In the first weeks after transmission, the majority of donor-derived mutations in and outside donor-HLA-restricted epitopes in Gag, Env, and Nef, were preserved in the recipient. Reversion to the HIV-1 subtype B consensus sequence of mutations in- and outside donor-HLA-restricted CTL epitopes, and new mutations away from the consensus B sequence mostly within recipient-HLA-restricted epitopes, contributed equally to the early sequence changes. In the subsequent period (1-2 years) after transmission, still only a low number of both reverting and forward mutations had occurred. During subsequent long-term follow-up, sequence dynamics were dominated by forward mutations, mostly (50-85%) in recipient-HLA-restricted CTL epitopes. At the end of long-term follow-up, on average 43% of the transmitted CTL escape mutations in donor-HLA-restricted epitopes had reverted to the subtype B consensus sequence. CONCLUSIONS/SIGNIFICANCE: The relatively high proportion of long-term preserved mutations after transmission points to a lack of back selection even in the absence of CTL pressure, which may lead to an accumulating loss of critical CTL epitopes. Our data are supportive for a continuous adaptation of HIV-1 to host immune pressures which may have implications for vaccine design.


Subject(s)
Evolution, Molecular , HIV-1/genetics , HLA Antigens/immunology , Tissue Donors , Base Sequence , DNA Primers , HLA Antigens/genetics , Histocompatibility Testing , Mutation , Phylogeny , Polymerase Chain Reaction , RNA, Viral/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...